About

Provided by Hogan Lovells

We know how overwhelming it can be trying to effectively navigate today’s regulatory environment and capitalize on strategic opportunities. Many members of our team have previously worked in key positions in both the private and public sectors, including the U.S. Department of Health and Human Services (HHS), the Centers for Medicare & Medicaid Services (CMS), and the Federal Trade Commission (FTC).

Having an in-depth understanding of the relationship between the government and global health care marketplace allows us to counsel you effectively on legal and regulatory issues — and to be your strategic advisor, litigator, and dealmaker, too. 

Our health care transactions team leads the nation in the number of complex hospital, academic medical centers, and health system transactions it has handled. Combining our technical and industry knowledge enables us to understand your objectives, plan for the positions likely to be taken by other parties, and help you develop the best deal structure
and strategy.

Chambers Review

Provided by Chambers

Healthcare - District of Columbia

1
Band 1

What the Team is Known For

Hogan Lovells is a distinguished team with deep expertise across the scope of the healthcare and life sciences industries. The firm handles complex issues including the regulation of new medical devices, biotechnology products and healthcare litigation, government price reporting, privacy and reimbursement issues and digital health. The team's expertise also extends to advising on transactions such as clinical integrations, M&A and contracting.

Work Highlights

  • Hogan Lovells US LLP successfully represented Danco Laboratories in a lawsuit seeking to revoke the FDA's approval of Danco's product Mifeprex, a drug approved to medically terminate pregnancy.

Strengths

Provided by Chambers

Notable Practitioners

Provided by Chambers

S
Helen R Trilling
S
Senior Statespeople
Helen Trilling is regulatory and compliance counsel for a range of high-profile medical device companies. She is also well versed in transactional matters, including acquisitions and corporate restructurings.
S
Jonathan S Kahan
S
Senior Statespeople
Jonathan Kahan has extensive expertise in FDA matters, including marketing compliance and the development of innovative medical devices.

Jonathan is fantastic; he is extremely knowledgeable, practical and easy to understand in a space which can be really convoluted. He helps move things along and has a great relationship with the FDA.

Robert F Leibenluft
S
Robert F Leibenluft
S
Senior Statespeople
Robert Leibenluft has notable expertise in representing healthcare networks and academic institutions involved in transactions such as big-ticket mergers. He also counsels on antitrust-related issues.
1
David Fox
1
Band 1
David Fox is a leading expert in FDA regulatory work. He represents an array of new and well-established life sciences companies involved in cutting-edge pharmaceutical matters.

David is top-notch. He just has exceptional judgment and really wonderful writing skills. He is a preeminent expert.

Jonathan L. Diesenhaus
1
Jonathan L. Diesenhaus
1
Band 1

Jonathan Diesenhaus of Hogan Lovells US is notable for his impressive healthcare litigation practice. He is a strong choice for hospitals facing complex disputes, and regularly takes on sophisticated FCA litigation.

Jonathan is knowledgeable and cool under pressure. He is very responsive, always reachable and terrific.

1
Philip Katz
1
Band 1

Philip Katz of Hogan Lovells US LLP is well noted for his expertise in an array of FDA matters. He has strength in issues relating to orphan drugs designation and regulatory exclusivity.

2
Beth L Roberts
2
Band 2
Beth Roberts is highly regarded for her expertise in reimbursement matters arising from the development of new treatments and diagnostic tools, including devices that use artificial intelligence.

Beth is up to date on trends and challenges and she can inform you to make a good decision. She really goes above and beyond to make sure everyone is well aware of the choices.

Beth is one of the most experienced and trusted attorneys in the country when it comes to matters involving Medicare coverage and reimbursement for medical technology.

Beth combines political savviness with deep policy expertise. She has an ability to cut through complex problems and formulate coherent and compelling messages customized to resonate with CMS staff.

2
David Horowitz
2
Band 2
David Horowitz draws on his extensive experience during his tenure at HHS and FDA. He is renowned for his ability to advise pharmaceutical clients on a range of regulatory issues.

David has great depth of knowledge and significant scientific expertise. He provides insightful and thorough advice and is well respected by agency personnel.

David's communication is efficient and timely. He meets the needs and he worked seamlessly and effectively.

2
Michael Heyl
2
Band 2
Michael Heyl advises medical and diagnostic device manufacturers on a broad range of FDA regulation matters. He has expertise in dealing with cross-border issues.

I can trust that Michael will provide timely, practical and informed advice in a right-sized manner.

Michael is so knowledgeable in a niche space. His intellect is his strength. He understands risk tolerance and has a strong sense of where agencies are focusing, which provides predictability.

2
Sheree R. Kanner
2
Band 2
Sheree Kanner offers deep expertise in Medicare and Medicaid litigation and regulatory compliance.
3
Alice Valder Curran
3
Band 3
Alice Valder Curran offers significant strength in pricing issues, including coverage and reimbursement. She also counsels on wider regulatory matters and government investigations.

Alice is an absolute expert in price reporting issues. She is always available to address complex issues in a way that makes it practical for us to devise strategies and weave through difficult areas.

Alice is very practical and gives great advice.

3
Clifford D Stromberg
3
Band 3
Clifford Stromberg handles M&A for prominent health systems and networks across the country. He counsels on transaction-related regulatory issues and antitrust matters.
3
Ken Choe
3
Band 3
Ken Choe has particular expertise in advising pharmaceutical manufacturers on pricing matters. He also has strength in governmental investigations and regulatory issues arising from the Affordable Care Act.
3
Meredith Manning
3
Band 3

Meredith Manning comes highly recommended for her longstanding regulatory expertise, which sees her regularly work with a range of pharmaceuticals. She is equally adept at providing compliance counsel and advising on investigations conducted by entities such as the FDA.

Meredith has been amazing. She is doing cutting-edge legal work and is really helpful, amazing and ground-breaking.

3
Ronald Wisor
Head of Healthcare
3
Band 3
Ronald Wisor is the leader of the health practice. He advises an impressive healthcare client base on fraud and abuse, reimbursement and digital health-related issues.

Ronald gives very good, practical guidance and knows what he is doing.

Ronald's industry knowledge is invaluable.

4
John J Smith
4
Band 4
Former clinician John Smith continues to develop a strong regulatory practice assisting pharmaceutical and medical products manufacturers in a wide range of issues, including FDA clearance.
4
Lynn Mehler
4
Band 4

Lynn Mehler of Hogan Lovells US LLP handles a range of FDA regulatory matters for pharmaceutical clients, from approvals to risk evaluation strategies.

Lynn's knowledge of how the FDA works and representation of many parties in this area gives her a perspective that no one else has.

Ranked Lawyers at
Hogan Lovells

Provided by Chambers
Filter by
Band

District of Columbia

Healthcare

S
Helen R Trilling
S
Senior Statespeople
Robert F Leibenluft
S
Robert F Leibenluft
S
Senior Statespeople
Jonathan L. Diesenhaus
1
Jonathan L. Diesenhaus
1
Band 1
2
Beth L Roberts
2
Band 2
2
Sheree R. Kanner
2
Band 2
3
Alice Valder Curran
3
Band 3
3
Clifford D Stromberg
3
Band 3
3
Ken Choe
3
Band 3
3
Ronald Wisor
Head of Healthcare
3
Band 3
Healthcare: Pharmaceutical/Medical Products Regulatory

S
Jonathan S Kahan
S
Senior Statespeople
1
David Fox
1
Band 1
1
Philip Katz
1
Band 1
2
David Horowitz
2
Band 2
2
Michael Heyl
2
Band 2
3
Meredith Manning
3
Band 3
4
John J Smith
4
Band 4
4
Lynn Mehler
4
Band 4